Tumour Lysis Syndrome by Tiza Chipungu - Oncology-unza

Description

This oncology presentation on Tumour Lysis Syndrome (TLS) provides a detailed overview of its definition, epidemiology, risk factors, pathophysiology, clinical presentation, and management. The material defines TLS as a metabolic emergency resulting from rapid tumor cell lysis, commonly associated with hematologic malignancies like acute lymphoblastic leukemia and Burkitt lymphoma, leading to hyperkalemia, hyperphosphatemia, hypocalcemia, hyperuricemia, and acute kidney injury. Key risk factors include high tumor burden, rapidly dividing tumors, preexisting renal impairment, and dehydration. Clinical features encompass neuromuscular symptoms, cardiac arrhythmias, oliguria, and renal dysfunction. Management focuses on risk assessment, prophylaxis with hydration and allopurinol or rasburicase, and targeted therapy for metabolic derangements. This resource is essential for medical students, oncology trainees, and practitioners in Zambia, offering structured, exam-focused content for understanding and managing TLS within a tertiary medical education setting. Download these comprehensive notes for thorough preparation on oncologic emergencies.